---
title: "Livento Group, Inc. | 10-Q: FY2025 Q2 Revenue: USD 234.13 K"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/252258203.md"
published_at: "2025-08-08T14:13:57.000Z"
---

# Livento Group, Inc. | 10-Q: FY2025 Q2 Revenue: USD 234.13 K

Revenue: As of FY2025 Q2, the actual value is USD 234.13 K.

EPS: As of FY2025 Q2, the actual value is USD 0.

### Segment Revenue

-   **Total Revenue**: For the three months ended June 30, 2025, Livento Group, Inc. reported revenues of $769,731, primarily from sales of Elisee, management services for Global Dot Logistics, and movie projects under BOXO Productions.

### Operational Metrics

-   **Net Income**: The company reported a net income of $147,331 for the three months ended June 30, 2025, compared to $262,792 for the same period in 2024.
-   **Gross Profit**: The gross profit for the three months ended June 30, 2025, was -$356,909, compared to -$68,208 for the same period in 2024.
-   **Operating Expenses**: Selling, general, and administrative expenses totaled approximately $11,321 for the three months ended June 30, 2025, compared to $16,178 for the same period in 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash provided by operating activities was $508,252 for the three months ended June 30, 2025, compared to -$40,061 for the same period in 2024.
-   **Free Cash Flow**: Not explicitly stated, but net cash increase for the period was $40,573.

### Unique Metrics

-   **Other Income**: The company reported other income of $535,600 for the three months ended June 30, 2025, primarily from movie projects.

### Future Outlook and Strategy

-   **Core Business Focus**: Livento Group, Inc. plans to continue focusing on its software product Elisee and movie projects under BOXO Productions, with expectations of increased revenue from these segments as new opportunities arise post-FINRA approval.
-   **Non-Core Business**: The company is also exploring growth in its management services for Global Dot Logistics, which is expected to contribute to future revenue streams.

### Related Stocks

- [NUGN.US - Livento Group, Inc.](https://longbridge.com/en/quote/NUGN.US.md)
- [NUGND.US - LIVENTO GROUP INC](https://longbridge.com/en/quote/NUGND.US.md)
- [LIVG.US - Livento Group, Inc.](https://longbridge.com/en/quote/LIVG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Livento 集團發佈修正案，確認進行 1 比 20,000 的反向股票拆分 | Livento Group Inc. 已確認於 2025 年 5 月 5 日獲得股東批准的 1 比 20,000 的反向股票拆分。該公司已提交修訂後的公司章程證明，以反映這一變化。此信息基於 Livento Group Inc.通過 EDG | [Link](https://longbridge.com/en/news/274006335.md) |
| NuGen Medical Devices Inc. 更新了關於加拿大衞生部許可證的情況 | NuGen Medical Devices Inc. 已暫時停止在加拿大銷售其設備，原因是其健康加拿大許可證到期，因未及時續期而失效。此情況並不構成安全風險，公司已提交新的許可證申請，並與健康加拿大保持溝通。NuGen 預計許可證將很快獲得 | [Link](https://longbridge.com/en/news/275039972.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.